Key statistics
On Thursday, Oruka Therapeutics Inc (HQ1:DEU) closed at 25.00, 49.34% above the 52 week low of 16.74 set on Feb 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.00 |
---|---|
High | 25.00 |
Low | 25.00 |
Bid | -- |
Offer | -- |
Previous close | 25.00 |
Average volume | -- |
---|---|
Shares outstanding | 35.00m |
Free float | 34.91m |
P/E (TTM) | -- |
Market cap | 874.96m USD |
EPS (TTM) | -5.97 USD |
Data delayed at least 15 minutes, as of Sep 05 2024.
More ▼
Announcements
- Oruka Therapeutics Announces $200 Million Private Placement
- Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19
- Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million